BroadcomvsClinuvel Pharmaceuticals

AVGO and CUVL stock compared: price, dividend, valuation and results, from SEC filings.

AVGO

Broadcom Inc.

$303.36

Value $1.44T

-12.58%
AVGO's page

CUVL

Clinuvel Pharmaceuticals Limited

$4.66

Value $235M

-1.06%
CUVL's page

Broadcom (AVGO) has a market value of $1.44T and Clinuvel Pharmaceuticals (CUVL) $235M. Over the last year, with dividends, AVGO moved -13.7% and CUVL -32.5%. The P/E is 37.6 for AVGO and 10.1 for CUVL. Dividend yield: AVGO 0.86%, CUVL 0.71%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    AVGO$1.44T

    CUVL$235M

    AVGO is 6,121 times CUVL

  • Revenue, 12 months

    AVGO$89.1B

    CUVL$64M

    AVGO is 1,385 times CUVL

  • Net income, 12 months

    AVGO$38.3B

    CUVL$23M

    AVGO is 1,651 times CUVL

  • Operating margin

    AVGO48.1%

    CUVL43.4%

    4.7 points apart

  • ROIC

    AVGO27.3%

    CUVL11.7%

    15.6 points apart

  • P/E

    AVGO37.6

    CUVL10.1

    AVGO is 3.7 times CUVL

  • Dividend yield

    AVGO0.9%

    CUVL0.7%

    0.2 points apart

  • 5-year return

    AVGO+483.6%

    CUVL-79.3%

    562.9 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

AVGO+483.6%

CUVL-79.3%

025050075020222023202420252026
Returns by period
PeriodAVGOWith dividendsCUVLWith dividends
1 year since November 19, 2025-13.7%Price -14.3%-32.5%Price -32.9%
3 years since November 20, 2023+215.1%+46.6% a yearPrice +205.1%-54.9%-23.3% a yearPrice -55.3%
5 years since November 19, 2021+483.6%+42.3% a yearPrice +434.2%-79.3%-27.0% a yearPrice -79.6%
10 years since November 21, 2016+2,193.0%+36.8% a yearPrice +1,660.1%-20.9%-2.3% a yearPrice -22.3%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

AVGOBroadcomCUVLClinuvel Pharmaceuticals

Valuation

AVGOCUVL
Valuation
Price$303.36$4.66
Market value$1.44T$235M
Enterprise value (EV)$1.47T$61M
P/E37.610.1
P/E, 5-year median30.415.9
P/B14.41.3
EV/EBIT34.42.2
Free cash flow yield2.7%5.0%

Results and growth

AVGOCUVL
Results and growth
Revenue, 12 months$89.1B$64M
Net income, 12 months$38.3B$23M
Free cash flow, 12 months$39.4B$12M
Earnings per share, 12 months$7.84$0.46
Revenue growth, year on year23.9%5.2%
Revenue growth a year, past+21.7%over 5 years+5.4%over 2 years
EPS growth a year, past+49.8%over 5 years+0.0%over 2 years

Margins and returns on capital

AVGOCUVL
Margins and returns on capital
Gross margin68.8%82.9%
Operating margin48.1%43.4%
Net margin42.9%36.0%
ROIC27.3%11.7%
ROE45.4%12.3%

Balance sheet

AVGOCUVL
Balance sheet
Cash$24.0B$174M
Total debt$59.4B$1.3M
Net debt / EBITDA0.8-6.2
Interest cover13.7×–

Dividends and buybacks

AVGOCUVL
Dividends and buybacks
Dividend yield0.9%0.7%
Dividend per share, 12 months$2.60$0.03
Dividend growth a year, past+12.7%over 5 years–
Buyback yield0.2%–
Shareholder yield1.0%0.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: AVGO or CUVL

Didn't find what you were looking for?

Ask us
Which is bigger, Broadcom or Clinuvel Pharmaceuticals?

By market value, Broadcom ($1.44T) is about 6,120.6 times Clinuvel Pharmaceuticals ($235M), at today's prices.

How did AVGO and CUVL stock do over the last 10 years?

Since November 21, 2016, AVGO's price moved +1,660.1% and CUVL's -22.3%. With dividends: AVGO +2,193.0% (+36.8% a year), CUVL -20.9% (-2.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, AVGO or CUVL?

The dividend yield at today's price is 0.86% for Broadcom and 0.71% for Clinuvel Pharmaceuticals. Over the last twelve months they paid $2.60 and $0.03 per share.

What is the P/E of AVGO and CUVL?

At today's price, the P/E is 37.6 for AVGO and 10.1 for CUVL. The median of the last five years was 30.4 and 15.9, which shows where each stands against its own past.

Which has the higher profit margins, Broadcom or Clinuvel Pharmaceuticals?

Over the last twelve months, the net margin was 42.9% for Broadcom and 36.0% for Clinuvel Pharmaceuticals, and the operating margin 48.1% and 43.4%. Revenue was $89.1B and $64M.

Which is the better investment, Broadcom or Clinuvel Pharmaceuticals?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.